Production (Stage)
Xenon Pharmaceuticals Inc.
XENE
$29.75
-$0.74-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 549.63M | 626.91M | 654.02M | 721.54M | 699.60M |
| Total Receivables | 8.65M | 1.47M | 938.00K | 853.00K | 833.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.26M | 6.89M | 4.69M | 5.70M | 6.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 565.54M | 635.26M | 659.64M | 728.09M | 707.20M |
|
|
|||||
| Total Current Assets | 565.54M | 635.26M | 659.64M | 728.09M | 707.20M |
| Net Property, Plant & Equipment | 17.31M | 18.22M | 18.42M | 18.71M | 18.28M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.93M | 17.16M | 8.53M | 8.15M | 7.71M |
| Total Assets | 743.28M | 798.14M | 835.90M | 884.01M | 919.02M |
|
|
|||||
| Total Accounts Payable | 6.88M | 5.07M | 5.43M | 9.50M | 6.43M |
| Total Accrued Expenses | 16.76M | 22.75M | 21.80M | 19.34M | 14.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.38M | 1.37M | 1.39M | 1.35M | 1.32M |
| Total Finance Division Other Current Liabilities | 7.01M | 6.40M | 1.08M | 1.10M | 106.00K |
| Total Other Current Liabilities | 7.01M | 6.40M | 1.08M | 1.10M | 106.00K |
| Total Current Liabilities | 32.03M | 35.59M | 29.70M | 31.29M | 22.22M |
|
|
|||||
| Total Current Liabilities | 32.03M | 35.59M | 29.70M | 31.29M | 22.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.29M | 7.65M | 8.40M | 8.68M | 9.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 39.32M | 43.24M | 38.09M | 39.96M | 31.33M |
|
|
|||||
| Common Stock & APIC | 1.67B | 1.66B | 1.63B | 1.62B | 1.60B |
| Retained Earnings | -964.52M | -899.47M | -833.79M | -771.00M | -713.07M |
| Treasury Stock & Other | -836.00K | -1.61M | 1.34M | -2.21M | -1.77M |
| Total Common Equity | 703.96M | 754.90M | 797.81M | 844.05M | 887.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 703.96M | 754.90M | 797.81M | 844.05M | 887.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 703.96M | 754.90M | 797.81M | 844.05M | 887.70M |
|
|
|||||